Got $10 billion? Don’t blow it cloning a woolly mammoth.
Colossal Biosciences, a Dallas-based biotechnology and genetic engineering startup valued at $10 billion, has raised $435 million to "de-extinct” the woolly mammoth.
Tomas Kauer - News Moderator 
Colossal Biosciences, a Dallas-based biotechnology and genetic engineering startup valued at $10 billion, has raised $435 million to "de-extinct” the woolly mammoth.
